208 related articles for article (PubMed ID: 27161874)
21. Synthesis and anti-human immunodeficiency virus type 1 integrase activity of hydroxybenzoic and hydroxycinnamic acid flavon-3-yl esters.
Desideri N; Sestili I; Stein ML; Tramontano E; Corrias S; La Colla P
Antivir Chem Chemother; 1998 Nov; 9(6):497-509. PubMed ID: 9865388
[TBL] [Abstract][Full Text] [Related]
22. Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays.
Hu G; Li X; Zhang X; Li Y; Ma L; Yang LM; Liu G; Li W; Huang J; Shen X; Hu L; Zheng YT; Tang Y
J Med Chem; 2012 Nov; 55(22):10108-17. PubMed ID: 23046280
[TBL] [Abstract][Full Text] [Related]
23. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3.
Cianci J; Baell JB; Flynn BL; Gable RW; Mould JA; Paul D; Harvey AJ
Bioorg Med Chem Lett; 2008 Mar; 18(6):2055-61. PubMed ID: 18289849
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of C-2 and C-3 substituted quinolines and their evaluation as anti-HIV-1 agents.
Shah P; Naik D; Jariwala N; Bhadane D; Kumar S; Kulkarni S; Bhutani KK; Singh IP
Bioorg Chem; 2018 Oct; 80():591-601. PubMed ID: 30036815
[TBL] [Abstract][Full Text] [Related]
26. Microwave-Assisted, Asymmetric Synthesis of 3-Amino-2,3-Dihydrobenzofuran Flavonoid Derivatives from Chalcones.
Helgren TR; Xu LL; Sotelo D; Mehta YR; Korkmaz MA; Pavlinov I; Aldrich LN
Chemistry; 2018 Mar; 24(18):4509-4514. PubMed ID: 29446184
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of C3 substituted chalcone-based derivatives of 7-azaindole as protein kinase inhibitors.
Qhobosheane MA; Legoabe LJ; Josselin B; Bach S; Ruchaud S; Beteck RM
Chem Biol Drug Des; 2020 Dec; 96(6):1395-1407. PubMed ID: 32558155
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and structure-activity relationship studies of furan-ring fused chalcones as antiproliferative agents.
Saito Y; Kishimoto M; Yoshizawa Y; Kawaii S
Anticancer Res; 2015 Feb; 35(2):811-7. PubMed ID: 25667461
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
Hammuda A; Shalaby R; Rovida S; Edmondson DE; Binda C; Khalil A
Eur J Med Chem; 2016 May; 114():162-9. PubMed ID: 26974383
[TBL] [Abstract][Full Text] [Related]
30. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
Ng HL; Chen S; Chew EH; Chui WK
Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
[TBL] [Abstract][Full Text] [Related]
31. Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2',3'-seco-3'-nor DCP and DCK analogues.
Chen Y; Cheng M; Liu FQ; Xia P; Qian K; Yu D; Xia Y; Yang ZY; Chen CH; Morris-Natschke SL; Lee KH
Eur J Med Chem; 2011 Oct; 46(10):4924-36. PubMed ID: 21864952
[TBL] [Abstract][Full Text] [Related]
32. Gold(I) complex of 1,1'-bis(diphenylphosphino) ferrocene-quinoline conjugate: a virostatic agent against HIV-1.
Gama N; Kumar K; Ekengard E; Haukka M; Darkwa J; Nordlander E; Meyer D
Biometals; 2016 Jun; 29(3):389-97. PubMed ID: 26922346
[TBL] [Abstract][Full Text] [Related]
33. Benzofuran-chalcone hybrids as potential multifunctional agents against Alzheimer's disease: synthesis and in vivo studies with transgenic Caenorhabditis elegans.
Sashidhara KV; Modukuri RK; Jadiya P; Dodda RP; Kumar M; Sridhar B; Kumar V; Haque R; Siddiqi MI; Nazir A
ChemMedChem; 2014 Dec; 9(12):2671-84. PubMed ID: 25251917
[TBL] [Abstract][Full Text] [Related]
34. Geranylated or prenylated flavonoids from Cajanus volubilis.
Rao L; Su Y; He Q; Ye J; Liu Y; Fan Y; Hu F; Zhou Z; Gan L; Zhang Y; Zhang C
Chin J Nat Med; 2023 Apr; 21(4):292-297. PubMed ID: 37120247
[TBL] [Abstract][Full Text] [Related]
35. Design of potent fluoro-substituted chalcones as antimicrobial agents.
Burmaoglu S; Algul O; Gobek A; Aktas Anil D; Ulger M; Erturk BG; Kaplan E; Dogen A; Aslan G
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):490-495. PubMed ID: 28118738
[TBL] [Abstract][Full Text] [Related]
36. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
37. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method.
Sivakumar PM; Geetha Babu SK; Mukesh D
Chem Pharm Bull (Tokyo); 2007 Jan; 55(1):44-9. PubMed ID: 17202700
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional suppression of the HIV promoter by natural compounds.
Uchiumi F; Hatano T; Ito H; Yoshida T; Tanuma S
Antiviral Res; 2003 Mar; 58(1):89-98. PubMed ID: 12719011
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of hydroxy substituted amino chalcone compounds for antityrosinase activity in B16 cells.
Radhakrishnan S; Shimmon R; Conn C; Baker A
Bioorg Chem; 2015 Oct; 62():117-23. PubMed ID: 26333206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
